Cost of revenue · 2016–2025
Usana Health Sciences cost of revenue
$201M+24.6% · FY2025
Usana Health Sciences (USNA) reported $201M in cost of revenue for fiscal 2025, +24.6% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252026-01-03 | $201M | +24.6% | Open → |
| FY20242024-12-28 | $161M | −8.8% | Open → |
| FY20232023-12-30 | $177M | −8.9% | Open → |
| FY20222022-12-31 | $194M | −11.0% | Open → |
| FY20212022-01-01 | $218M | +4.2% | Open → |
| FY20202021-01-02 | $209M | +11.5% | Open → |
| FY20192019-12-28 | $188M | −6.6% | Open → |
| FY20182018-12-29 | $201M | +11.9% | Open → |
| FY20172017-12-30 | $179M | −0.4% | Open → |
| FY20162016-12-31 | $180M | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +1.2%
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Usana Health Sciences cost of revenue |url=https://companiesranked.com/en/company/usana-health-sciences/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Usana Health Sciences cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/usana-health-sciences/cost-of-revenueBibTeX
@misc{companiesranked-en-company-usana-health-sciences-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Usana Health Sciences cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/usana-health-sciences/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000896264-26-000021 · March 16, 2026
{{cite web |title=Usana Health Sciences cost of revenue — 10-K (0000896264-26-000021) |url=https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-16}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.